IGFBP3 and gastrointestinal stromal tumor: To determine whether IGFBP3 contributes to GIST cell response or resistance to imatinib, we modulated IGFBP3 protein levels in GIST882 and GIST-T1 cells and assayed for potential changes in imatinib sensitivity.